EUVIMEDEUVIMED entdecken
Crossref

Decoding Acute Myeloid Leukemia Heterogeneity: A Multi-Omics Factor Analysis of Therapeutic Vulnerabilities and Clinical Outcomes

Bahar Tercan

Black Sea Journal of Engineering and Science · 15.05.2026 · 9 (3) · 1183-1190

DOI: 10.34248/bsengineering.1872623 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Black Sea Journal of Engineering and Science, online erschienen am 15.05.2026. Verfasst von Bahar Tercan. Die Arbeit nennt 17 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Acute myeloid leukemia (AML) is characterized by profound biological and clinical heterogeneity, where traditional mutation-centric frameworks often fail to fully capture the complex interplay between genomic drivers and functional phenotypes. In this study, we employed Multi-Omic Factor Analysis (MOFA) to integrate transcriptomic, mutational, pharmacological, and clinical data from a focused cohort of treatment-naïve de novo AML specimens. By utilizing a Bayesian framework, we identified nine latent factors that collapse high-dimensional data into distinct biological axes, explaining the majority of variance in the transcriptomic (54.5%) and clinical (23.7%) modalities. Our results characterized Factor 1 as a monocytic differentiation axis defined by high expression of mature myeloid markers such as CD14 and S100A8/9. Furthermore, the integration of MOFA-derived factors with the European LeukemiaNet (ELN) 2022 risk classification improved predictive accuracy, increasing the Harrell’s C-index from 0.66 to 0.72. These findings conclude that "molecularly silent" variance—biology not captured by somatic mutations alone—is a critical determinant of chemotherapy response and clinical outcome. Ultimately, this work provides a robust framework for transitioning toward a functional, multi-omic approach for personalized therapeutic selection and more precise risk assessment in AML.

Zitieren

APA

Tercan, B. (2026). Decoding Acute Myeloid Leukemia Heterogeneity: A Multi-Omics Factor Analysis of Therapeutic Vulnerabilities and Clinical Outcomes. Black Sea Journal of Engineering and Science, 9(3), 1183-1190. https://doi.org/10.34248/bsengineering.1872623

Vancouver

Tercan B. Decoding Acute Myeloid Leukemia Heterogeneity: A Multi-Omics Factor Analysis of Therapeutic Vulnerabilities and Clinical Outcomes. Black Sea Journal of Engineering and Science. 2026;9(3):1183-1190. doi:10.34248/bsengineering.1872623

BibTeX
@article{Tercan2026,
  author = {Tercan, Bahar},
  title = {Decoding Acute Myeloid Leukemia Heterogeneity: A Multi-Omics Factor Analysis of Therapeutic Vulnerabilities and Clinical Outcomes},
  journal = {Black Sea Journal of Engineering and Science},
  year = {2026},
  volume = {9},
  number = {3},
  pages = {1183--1190},
  doi = {10.34248/bsengineering.1872623}
}
Kostenlos starten →